A multinational survey of pediatric nephrologists found no intercountry difference in the rate at which renal replacement therapy is offered to infants with end-stage renal disease. Overall, renal replacement therapy is offered by 41% to all infants < 1 month old and by 53% to all infants between 1 and 12 months.